What is Leerink Partnrs’ Estimate for BNTC FY2025 Earnings?

Benitec Biopharma Inc. (NASDAQ:BNTC – Free Report) – Analysts at Leerink Partnrs lifted their FY2025 EPS estimates for shares of Benitec Biopharma in a report issued on Wednesday, May 14th. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology company will post earnings of ($1.18) per share for the year, up from their previous […]

Leave a Reply

Your email address will not be published.

Previous post NetApp (NASDAQ:NTAP) Price Target Raised to $105.00
Next post Iris Energy FY2025 EPS Estimate Reduced by HC Wainwright